Similar to BRCA1/2 playing a crucial role in the HRR process (2), the satisfactory performance of the CNV of 8q24.2 in predicting pan-cancer HRD led us to speculate that some genes on this fragment may influence the HRD status of patients through an intrinsic mechanism. This evidence concerns the gene BRCA1 and cancer.